News
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea ...
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
Weight loss can improve ... or have more severe sleep apnea, usually need a full-face mask.(Photo Credit: Jean Paul Chassenet/Dreamstime) You may be able to treat mild symptoms with some lifestyle ...
Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.
Medicare covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and ... access GLP-1s for weight loss. Meanwhile, the Food and Drug Administration ...
Dr. Katherine Saunders, at Weill Cornell Medicine, joined ABC News' to discuss a new daily weight loss pill by Eli Lilly saying it "opens up opportunities" to treat diseases. Dr. Rekha Kumar ...
Some steps that a person can take to lose weight include: In addition to lifestyle changes that promote weight loss ... doctors may also recommend surgery to treat sleep apnea, especially in ...
Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes ... Type 2 diabetes, sleep apnea or heart disease.
People suffering from sleep issues may soon be able to rest easier, thanks to a new wearable device that could revolutionize the way we get our shut-eye. Unveiled at the American Thoracic Society ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results